MarketCap
Facebook
X
TelegramQuartalsbericht 2025-Q3
hinzugefügt 03.11.2025
Solid Biosciences Langfristiger Schuldenstrom 2011-2026 | SLDB
Langfristiger Schuldenstrom Jährlich Solid Biosciences
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.79 M | 1.86 M | 1.9 M | 1.26 M | 2 M | 1.74 M | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 2 M | 1.26 M | 1.76 M |
Langfristiger Schuldenstrom anderer Aktien in der Arzneimittelhersteller
| Name | Langfristiger Schuldenstrom | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
AcelRx Pharmaceuticals
ACRX
|
5.36 M | - | 7.5 % | $ 6.35 M |  USA |
 |
Aerie Pharmaceuticals
AERI
|
4.36 M | - | - | $ 754 M | USA |
 |
Alimera Sciences
ALIM
|
634 K | - | - | $ 142 M | USA |
 |
Agile Therapeutics
AGRX
|
366 K | - | 10.11 % | $ 58.2 M | USA |
 |
Adamis Pharmaceuticals Corporation
ADMP
|
343 K | - | 0.86 % | $ 117 M | USA |
 |
Avadel Pharmaceuticals plc
AVDL
|
582 K | $ 21.64 | 0.05 % | $ 2.06 B |  France |
 |
Canopy Growth Corporation
CGC
|
7.46 M | $ 1.07 | - | $ 115 M |  Canada |
 |
Catalent
CTLT
|
13 M | - | - | $ 11.5 B | USA |
 |
DURECT Corporation
DRRX
|
1.38 M | - | - | $ 50.1 M | USA |
 |
Cumberland Pharmaceuticals
CPIX
|
357 K | $ 3.87 | 0.26 % | $ 54.4 M | USA |
 |
Calliditas Therapeutics AB (publ)
CALT
|
3.91 M | - | -0.1 % | $ 2.03 B |  Schweden |
 |
Eagle Pharmaceuticals
EGRX
|
1.53 M | - | -39.89 % | $ 27.7 M | USA |
 |
Endo International plc
ENDP
|
956 K | - | - | $ 28.9 M |  Irlanda |
 |
HEXO Corp.
HEXO
|
914 K | - | 2.45 % | $ 38.1 M | Canada |
 |
Evoke Pharma
EVOK
|
13.4 K | - | - | $ 36.6 M | USA |
 |
Emergent BioSolutions
EBS
|
3.5 M | $ 11.03 | 0.14 % | $ 565 M | USA |
 |
Athenex
ATNX
|
2.09 M | - | -23.39 % | $ 1.76 M | USA |
 |
Jupiter Wellness
JUPW
|
213 K | - | - | $ 33.6 M | USA |
 |
Evolus
EOLS
|
1.72 M | $ 4.3 | - | $ 267 M | USA |
 |
China Pharma Holdings
CPHI
|
39.3 K | $ 0.63 | -4.99 % | $ 11 M |  China |
 |
Harrow Health
HROW
|
806 K | $ 48.66 | - | $ 1.59 B | USA |
 |
OrganiGram Holdings
OGI
|
1.03 M | $ 1.31 | - | $ 402 M | Canada |
 |
Pacira BioSciences
PCRX
|
8.89 M | $ 21.73 | 2.31 % | $ 1 B | USA |
 |
Lannett Company
LCI
|
2.06 M | - | 1.15 % | $ 7.11 M | USA |
 |
Bausch Health Companies
BHC
|
61 M | $ 6.08 | - | $ 2.22 B | Canada |
 |
Sundial Growers
SNDL
|
34.3 M | $ 1.5 | - | $ 3.37 M | Canada |
 |
Neoleukin Therapeutics
NLTX
|
2.56 M | - | - | $ 193 M | Canada |
 |
Tilray
TLRY
|
2.47 M | $ 7.62 | -2.68 % | $ 4.71 B | Canada |
 |
Perrigo Company plc
PRGO
|
27.8 M | $ 14.6 | 1.46 % | $ 2.01 B | USA |
 |
Organogenesis Holdings
ORGO
|
4.27 M | $ 3.76 | -2.08 % | $ 495 M | USA |
 |
cbdMD
YCBD
|
98.7 K | $ 0.75 | 1.1 % | $ 3.23 M | USA |
 |
PetIQ
PETQ
|
7.61 M | - | 1.64 % | $ 400 M | USA |
 |
Aurora Cannabis
ACB
|
5.38 M | $ 3.44 | - | $ 86.3 M | Canada |
 |
ProPhase Labs
PRPH
|
301 K | - | - | $ 5.07 M | USA |
 |
Radius Health
RDUS
|
613 K | - | - | $ 1.42 B | USA |
 |
Recro Pharma
REPH
|
1.1 M | - | -4.76 % | $ 65.3 M | USA |
 |
Rockwell Medical
RMTI
|
1.38 M | $ 1.09 | - | $ 25.4 M | USA |
 |
OptiNose
OPTN
|
911 K | - | - | $ 1.08 B | USA |
 |
Assertio Holdings
ASRT
|
928 K | $ 11.95 | 2.31 % | $ 849 M | USA |
 |
PLx Pharma
PLXP
|
622 K | - | -27.8 % | $ 2.56 M | USA |
 |
Sonoma Pharmaceuticals
SNOA
|
58 K | $ 2.85 | 1.42 % | $ 3.54 M | USA |
 |
Zynerba Pharmaceuticals
ZYNE
|
215 K | - | - | $ 55.5 M | USA |
 |
SCYNEXIS
SCYX
|
340 K | $ 0.8 | -1.39 % | $ 38.3 M | USA |
 |
Veru
VERU
|
1.07 M | $ 2.3 | - | $ 310 M | USA |
 |
Tricida
TCDA
|
2.74 M | - | - | $ 3.25 M | USA |
 |
TherapeuticsMD
TXMD
|
1.47 M | $ 2.43 | 2.1 % | $ 25.4 M | USA |
 |
Viatris
VTRS
|
80.6 M | $ 16.13 | - | $ 19.6 B | USA |